1. Home
  2. Bills
  3. H.R. 3093

H.R. 3093 · 118th Congress · 2023–2024

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023

H.R. 3093 in the 118th Congress (2023–2024) was introduced on May 5, 2023, sponsored by Val T. Hoyle with 18 co-sponsors.

During the 118th Congress (2023–2024), Joe Biden was president, and Republicans held the House majority and Democrats the Senate majority.

Status
Introduced
Introduced
May 5, 2023
Co-sponsors
18
Policy area
Health

What it does

Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 202 3 This bill requires companies that receive federal funding for research (or a license of the rights to a patent or regulatory test data) for a biomedical product or service to agree to set reasonable prices for the resulting biomedical product or service.

Summary by the nonpartisan Congressional Research Service.

Sponsor

Val T. Hoyle (D-OR). Co-sponsors: 18 Democrats.

Where it stands

  • IntroducedMay 5, 2023
  • Passed the House—
  • Passed the Senate—
  • Sent to the President—
  • Became law—

Latest action: Referred to the Subcommittee on Health. (May 12, 2023)

More bills from Val T. Hoyle in the 118th Congress

Other Health bills in the 118th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 3093 (118th Congress): Affordable Pricing for Taxpayer-Funded…,” https://www.capitolreceipts.com/bill/118-hr-3093/affordable-pricing-for-taxpayer-funded-prescription-drugs-act-of (accessed 2026-10-17).